<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37773166</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2448-5667</ISSN><JournalIssue CitedMedium="Internet"><Volume>61</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>04</Day></PubDate></JournalIssue><Title>Revista medica del Instituto Mexicano del Seguro Social</Title><ISOAbbreviation>Rev Med Inst Mex Seguro Soc</ISOAbbreviation></Journal><ArticleTitle>[Parkinson-dementia and amyotrophic lateral sclerosis association (complex of Guam). Diagnostic challenge, Mexican patient].</ArticleTitle><Pagination><StartPage>677</StartPage><EndPage>684</EndPage><MedlinePgn>677-684</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5281/zenodo.8316479</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex (ALS-PDC) was first described in the islands of Guam. This pathology presented its peak incidence in the 1950s. Due to the rarity of the association, we report a clinical case with this complex. The objective was to describe the nosological and pathogenic implications of these neurodegenerative disorder, since they are not frequent to find in our population.</AbstractText><AbstractText Label="CLINICAL CASE" NlmCategory="UNASSIGNED">We present a case of Latinoamerican origin who initially manifested systemic symptoms of more than 6 years of evolution, with subsequent cognitive alterations. Later, patient began with gait disturbances and motor symptoms suggestive of parkinsonism with atypical data and data of motor neurone disease (MND). More studies were carried out and confirmed findings compatible with upper and lower motor neuron involvement. A mutation in the POLG gene was observed, related to mitochondrial depletion syndrome.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Despite the knowledge of this association, it is an entity whose clinical diagnosis could be very difficult to achieve. In addition, molecular mechanisms have not been fully identified, the most common genes related to Parkinsonism and ALS have been excluded, and even attempts to locate the locus were made, without achieving accurate results. Unfortunately, being a neurodegenerative disease, the prognosis is fatal, with no disease-modifying treatment.</AbstractText><CopyrightInformation>Licencia CC 4.0 (BY-NC-ND) &#xa9; 2023 Revista M&#xe9;dica del Instituto Mexicano del Seguro Social.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aguilar-V&#xe1;zquez</LastName><ForeName>Crhistian Alejandro</ForeName><Initials>CA</Initials><Identifier Source="ORCID">0000-0001-6400-2564</Identifier><AffiliationInfo><Affiliation>Instituto Mexicano del Seguro Social, Centro M&#xe9;dico Nacional Siglo XXI, Hospital de Especialidades "Dr. Bernardo Sep&#xfa;lveda Guti&#xe9;rrez", Servicio de Neurolog&#xed;a. Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallardo-Gonz&#xe1;lez</LastName><ForeName>Liliana Ivonne</ForeName><Initials>LI</Initials><Identifier Source="ORCID">0000-0002-7470-4217</Identifier><AffiliationInfo><Affiliation>Petr&#xf3;leos Mexicanos, Hospital Regional PEMEX Poza Rica, Servicio de Medicina Interna. Poza Rica, Veracruz, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raymundo-Carrillo</LastName><ForeName>Alejandra Diana</ForeName><Initials>AD</Initials><Identifier Source="ORCID">0000-0002-5125-6343</Identifier><AffiliationInfo><Affiliation>Petr&#xf3;leos Mexicanos, Hospital Regional PEMEX Poza Rica, Servicio de Medicina Interna. Poza Rica, Veracruz, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reyes-Sosa</LastName><ForeName>Luis Carlos</ForeName><Initials>LC</Initials><Identifier Source="ORCID">0000-0002-7646-507X</Identifier><AffiliationInfo><Affiliation>Instituto Mexicano del Seguro Social, Centro M&#xe9;dico Nacional Siglo XXI, Hospital de Especialidades "Dr. Bernardo Sep&#xfa;lveda Guti&#xe9;rrez", Servicio de Neurolog&#xed;a. Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez-Romo</LastName><ForeName>Elizabeth Scarlette</ForeName><Initials>ES</Initials><Identifier Source="ORCID">0000-0002-8681-1108</Identifier><AffiliationInfo><Affiliation>Petr&#xf3;leos Mexicanos, Hospital Regional PEMEX Poza Rica, Servicio de Medicina Interna. Poza Rica, Veracruz, M&#xe9;xico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Asociaci&#xf3;n Parkinson-demencia y esclerosis lateral amiotr&#xf3;fica (complejo Guam). Reto diagn&#xf3;stico, paciente mexicano.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Mexico</Country><MedlineTA>Rev Med Inst Mex Seguro Soc</MedlineTA><NlmUniqueID>101243727</NlmUniqueID><ISSNLinking>0443-5117</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006141" MajorTopicYN="N" Type="Geographic">Guam</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020734" MajorTopicYN="Y">Parkinsonian Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="INTRODUCCI&#xd3;N" NlmCategory="UNASSIGNED">el complejo parkinsonismo-demencia-esclerosis lateral amiotr&#xf3;fica fue descrito por primera vez en las islas de Guam. Esta patolog&#xed;a present&#xf3; su pico de incidencia en los a&#xf1;os 50. Debido a la rareza de la asociaci&#xf3;n, informamos sobre un caso cl&#xed;nico que la presenta. El objetivo fue describir las implicaciones nosol&#xf3;gicas y patog&#xe9;nicas de este trastorno neurodegenerativo, ya que no es frecuente encontrar esta asociaci&#xf3;n en nuestra poblaci&#xf3;n.</AbstractText><AbstractText Label="CASO CL&#xcd;NICO" NlmCategory="UNASSIGNED">presentamos un caso de origen latinoamericano que inicialmente se manifest&#xf3; con s&#xed;ntomas sist&#xe9;micos de m&#xe1;s de 6 a&#xf1;os de evoluci&#xf3;n, con posteriores alteraciones cognitivas. Despu&#xe9;s present&#xf3; alteraciones de la marcha y s&#xed;ntomas motores sugestivos de parkinsonismo con datos at&#xed;picos y datos de enfermedad de motoneurona. Se hicieron estudios de extensi&#xf3;n que confirmaron hallazgos compatibles con afectaci&#xf3;n en motoneurona superior e inferior. Observamos mutaci&#xf3;n en gen POLG, relacionada con s&#xed;ndrome de depleci&#xf3;n mitocondrial.</AbstractText><AbstractText Label="CONCLUSI&#xd3;N" NlmCategory="UNASSIGNED">a pesar del conocimiento de esta asociaci&#xf3;n, es una entidad cuyo diagn&#xf3;stico cl&#xed;nico puede ser muy dif&#xed;cil de obtener. Adem&#xe1;s, no se han identificado del todo los mecanismos moleculares, se han excluido los genes m&#xe1;s comunes relacionados con parkinsonismos y esclerosis lateral amiotr&#xf3;fica e incluso se intent&#xf3; localizar el locus, sin lograr resultados certeros. Desafortunadamente al ser una enfermedad neurodegenerativa el pron&#xf3;stico es fatal, sin que haya tratamiento modificador de la enfermedad.</AbstractText><CopyrightInformation>Licencia CC 4.0 (BY-NC-ND) &#xa9; 2023 Revista M&#xe9;dica del Instituto Mexicano del Seguro Social.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic Lateral Sclerosis</Keyword><Keyword MajorTopicYN="N">Dementia</Keyword><Keyword MajorTopicYN="N">Neurodegenerative Diseases</Keyword><Keyword MajorTopicYN="N">Parkinsonism</Keyword></KeywordList><CoiStatement>los autores han completado y enviado la forma traducida al espa&#xf1;ol de la declaraci&#xf3;n de conflictos potenciales de inter&#xe9;s del Comit&#xe9; Internacional de Editores de Revistas M&#xe9;dicas, y no fue reportado alguno que tuviera relaci&#xf3;n con este art&#xed;culo.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>29</Day><Hour>18</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>29</Day><Hour>12</Hour><Minute>34</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37773166</ArticleId><ArticleId IdType="pmc">PMC10599773</ArticleId><ArticleId IdType="doi">10.5281/zenodo.8316479</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Morris HR, Steele JC, Crook R, et al. Genome-wide analysis of the parkinsonism-dementia complex of Guam. Arch Neurol. 2004;61(12):1889&#x2013;1897. doi: 10.1001/archneur.61.12.1889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.61.12.1889</ArticleId><ArticleId IdType="pubmed">15596609</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez-Jer&#xf3;nino H, Hern&#xe1;ndez-Salazar M, Gonz&#xe1;lez-V&#xe1;zquez A, et al. Parkinson-plus: un desaf&#xed;o para su diagn&#xf3;stico y tratamiento. Rev Esp Med Quir. 2003;8(2):8&#x2013;14.</Citation></Reference><Reference><Citation>Arnold A, Edgren DC, Palladino VS. Amyotrophic lateral sclerosis; fifty cases observed on Guam. J Nerv Ment Dis. 1953;117(2):135&#x2013;139.</Citation><ArticleIdList><ArticleId IdType="pubmed">13061952</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato S, Oda M, Tanabe H. Diminution of dopaminergic neurons in the substantia nigra of sporadic amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol. 1993;19(4):300&#x2013;304. doi: 10.1111/j.1365-2990.1993.tb00444.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2990.1993.tb00444.x</ArticleId><ArticleId IdType="pubmed">7901781</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai J, Swash M. Extrapyramidal involvement in amyotrophic lateral sclerosis: backward falls and retropulsion. J Neurol Neurosurg Psychiatry. 1999;67(2):214&#x2013;216. doi: 10.1136/jnnp.67.2.214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.67.2.214</ArticleId><ArticleId IdType="pmc">PMC1736464</ArticleId><ArticleId IdType="pubmed">10406993</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeiren Y, Janssens J, Van-Dam D, et al. Serotonergic Dysfunction in Amyotrophic Lateral Sclerosis and Parkinson's Disease: Similar Mechanisms, Dissimilar Outcomes. Front Neurosci. 2018;12:185. doi: 10.3389/fnins.2018.00185.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00185</ArticleId><ArticleId IdType="pmc">PMC5869258</ArticleId><ArticleId IdType="pubmed">29615862</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazaki I, Asanuma M, Murakami S, et al. Targeting 5-HT(1A) receptors in astrocytes to protect dopaminergic neurons in Parkinsonian models. Neurobiol Dis. 2013;59:244&#x2013;256. doi: 10.1016/j.nbd.2013.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.08.003</ArticleId><ArticleId IdType="pubmed">23959140</ArticleId></ArticleIdList></Reference><Reference><Citation>De-Deurwaerd&#xe8;re P, Di-Giovanni G. Serotonergic modulation of the activity of mesencephalic dopaminergic systems: therapeutic implications. Prog Neurobiol. 2017;151:175&#x2013;236. doi: 10.1016/j.pneurobio.2016.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2016.03.004</ArticleId><ArticleId IdType="pubmed">27013075</ArticleId></ArticleIdList></Reference><Reference><Citation>Kokubo Y, Kuzuhara S. Neuroradiological study of patients with amyotrophic lateral sclerosis and parkinsonism-dementia complex on the Kii peninsula of Japan. Arch Neurol. 2003;60(9):1257&#x2013;1261. doi: 10.1001/archneur.60.9.1257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.60.9.1257</ArticleId><ArticleId IdType="pubmed">12975292</ArticleId></ArticleIdList></Reference><Reference><Citation>Kokubo Y, Morimoto S, Sasaki R, et al. An immigrant family with Kii amyotrophic lateral sclerosis/parkinsonism-dementia complex. Neurol Sci. 2022;43(2):1423&#x2013;1425. doi: 10.1007/s10072-021-05737-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05737-7</ArticleId><ArticleId IdType="pubmed">34779964</ArticleId></ArticleIdList></Reference><Reference><Citation>Poorkaj P, Tsuang D, Wijsman E, et al. TAU as a susceptibility gene for amyotropic lateral sclerosis-parkinsonism dementia complex of Guam. Arch Neurol. 2001;58(11):1871&#x2013;1878. doi: 10.1001/archneur.58.11.1871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.58.11.1871</ArticleId><ArticleId IdType="pubmed">11708997</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarranz JJ, Ferrer I, Lezcano E, et al. A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease. Neurology. 2005;64(9):1578&#x2013;1585. doi: 10.1212/01.WNL.0000160116.65034.12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000160116.65034.12</ArticleId><ArticleId IdType="pubmed">15883319</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilhelmsen KC, Forman MS, Rosen HJ, et al. 17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusions. Arch Neurol. 2004;61(3):398&#x2013;406. doi: 10.1001/archneur.61.3.398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.61.3.398</ArticleId><ArticleId IdType="pubmed">15023818</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013;9(11):617&#x2013;628. doi: 10.1038/nrneurol.2013.203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.203</ArticleId><ArticleId IdType="pubmed">24126629</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn C, Elman L. Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases. Continuum (Minneap Minn) 2020;26(5):1323&#x2013;1347. doi: 10.1212/CON.0000000000000911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CON.0000000000000911</ArticleId><ArticleId IdType="pubmed">33003004</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A, Drory V, Hardiman O, et al. A revision of the El Escorial criteria &#x2013; 2015. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(5-6):291&#x2013;292. doi: 10.3109/21678421.2015.1049183.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1049183</ArticleId><ArticleId IdType="pubmed">26121170</ArticleId></ArticleIdList></Reference><Reference><Citation>Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015;30(12):1591&#x2013;1601. doi: 10.1002/mds.26424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.26424</ArticleId><ArticleId IdType="pubmed">26474316</ArticleId></ArticleIdList></Reference><Reference><Citation>Park HK, Lim YM, Kim JS, et al. Nigrostriatal dysfunction in patients with amyotrophic lateral sclerosis and parkinsonism. J Neurol Sci. 2011;301(1-2):12&#x2013;13. doi: 10.1016/j.jns.2010.11.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2010.11.017</ArticleId><ArticleId IdType="pubmed">21167502</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradat PF, Bruneteau G, Munerati E, et al. Extrapyramidal stiffness in patients with amyotrophic lateral sclerosis. Mov Disord. 2009;24(14):2143&#x2013;2148. doi: 10.1002/mds.22762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.22762</ArticleId><ArticleId IdType="pubmed">19735090</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo T, Tan LC. 'Hummingbird' Sign in a Patient with Guam Parkinsonism-Dementia Complex. J Mov Disord. 2017;10(3):145&#x2013;148. doi: 10.14802/jmd.17025.</Citation><ArticleIdList><ArticleId IdType="doi">10.14802/jmd.17025</ArticleId><ArticleId IdType="pmc">PMC5615172</ArticleId><ArticleId IdType="pubmed">28782342</ArticleId></ArticleIdList></Reference><Reference><Citation>Gwathmey K. Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Its Variants. Continuum (Minneap Minn) 2020;26(5):1205&#x2013;1223. doi: 10.1212/CON.0000000000000907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CON.0000000000000907</ArticleId><ArticleId IdType="pubmed">33002999</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene P. Progressive Supranuclear Palsy, Corticobasal Degeneration, and Multiple System Atrophy. Continuum (Minneap Minn) 2019;25(4):919&#x2013;935. doi: 10.1212/CON.0000000000000751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CON.0000000000000751</ArticleId><ArticleId IdType="pubmed">31356287</ArticleId></ArticleIdList></Reference><Reference><Citation>Spencer PS, Palmer V, Kisby G. The ALS/PDC syndrome of Guam and the cycad hypothesis. Neurology. 2009;72(5):474&#x2013;476.</Citation><ArticleIdList><ArticleId IdType="pubmed">19195086</ArticleId></ArticleIdList></Reference><Reference><Citation>Dombroski BA, Galasko DR, Mata IF, et al. C9orf72 hexanucleotide repeat expansion and Guam amyotrophic lateral sclerosis-Parkinsonism-dementia complex. JAMA Neurol. 2013;70(6):742&#x2013;745. doi: 10.1001/jamaneurol.2013.1817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2013.1817</ArticleId><ArticleId IdType="pmc">PMC3771869</ArticleId><ArticleId IdType="pubmed">23588498</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantero V, Tarlarini C, Aliprandi A, et al. Genetic Counseling Dilemmas for a Patient with Sporadic Amyotrophic Lateral Sclerosis, Frontotemporal Degeneration &amp; Parkinson's Disease. J Genet Couns. 2017;26(3):442&#x2013;446. doi: 10.1007/s10897-017-0088-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10897-017-0088-5</ArticleId><ArticleId IdType="pubmed">28247171</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>